Momenta Shelves Adalimumab But Persists With Aflibercept

 
• By Aidan Fry
old books on the shelf - Image
Commercial considerations have led Momenta to shelve active development on its M923 adalimumab candidate • Source: Shutterstock

More from Biosimilars

More from Products